Little Difference with Oral Semaglutide vs Liraglutide in Diabetes
Oral semaglutide, an investigational agent, is noninferior to subcutaneous liraglutide in reducing HbA1c in patients with type 2 diabetes and superior in terms of weight loss, show results of the PIONEER 4 trial, the first study to compare the efficacy and safety of this form of semaglutide with liraglutide. The results were reported at the American Diabetes Association (ADA) 2019 Scientific Sessions.Also presented in a poster were findings from PIONEER 7, which compared the ef
Read the full story.
Create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies